{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:59:38Z","timestamp":1761861578541,"version":"build-2065373602"},"reference-count":91,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.mcna.2022.07.008","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T21:54:51Z","timestamp":1664834091000},"page":"1067-1080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Initiating Pharmacologic Treatment in Tobacco-Dependent Adults"],"prefix":"10.1016","volume":"106","author":[{"given":"Alejandra","family":"Ellison-Barnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagis","family":"Galiatsatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Vigi\u00e9","key":"10.1016\/j.mcna.2022.07.008_bib1"},{"issue":"9","key":"10.1016\/j.mcna.2022.07.008_bib2","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2105\/AJPH.2008.152983","article-title":"\"Everywhere the soldier will be\": wartime tobacco promotion in the US military","volume":"99","author":"Smith","year":"2009","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.mcna.2022.07.008_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2105\/AJPH.91.2.196","article-title":"Cigarettes and the US Public Health Service in the 1950s","volume":"91","author":"Parascandola","year":"2001","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.mcna.2022.07.008_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.thorsurg.2013.01.009","article-title":"Tobacco smoking: the leading cause of preventable disease worldwide","volume":"23","author":"Samet","year":"2013","journal-title":"Thorac Surg Clin"},{"year":"2020","series-title":"Smoking Cessation, A Report of the Surgeon General","key":"10.1016\/j.mcna.2022.07.008_bib5"},{"key":"10.1016\/j.mcna.2022.07.008_bib6","unstructured":"Services UDoHaH. Nicotine addiction: A report of the Surgeon General. DHHS Publication Number (CDC). 1988:88\u20138406."},{"key":"10.1016\/j.mcna.2022.07.008_bib7","unstructured":"Institute of Medicine (US) Committee to Assess the Science Base for Tobacco Harm Reduction; Stratton K, Shetty P, Wallace R, et al., editors. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction, Washington, DC, National Academies Press, US, 2001. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK222375\/"},{"issue":"4","key":"10.1016\/j.mcna.2022.07.008_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14728220902841045","article-title":"Nicotinic acetylcholine receptors: an overview on drug discovery","volume":"13","author":"D'Hoedt","year":"2009","journal-title":"Expert Opin Ther Targets"},{"issue":"7047","key":"10.1016\/j.mcna.2022.07.008_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature03694","article-title":"Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors","volume":"436","author":"Maskos","year":"2005","journal-title":"Nature"},{"issue":"6663","key":"10.1016\/j.mcna.2022.07.008_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/34413","article-title":"Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine","volume":"391","author":"Picciotto","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.mcna.2022.07.008_bib11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuropharm.2013.04.028","article-title":"Molecules and circuits involved in nicotine addiction: The many faces of smoking","volume":"76 Pt B","author":"Picciotto","year":"2014","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.mcna.2022.07.008_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","article-title":"It is not \"either\/or\": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood","volume":"84","author":"Picciotto","year":"2008","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.mcna.2022.07.008_bib13","unstructured":"Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK53017\/"},{"issue":"3","key":"10.1016\/j.mcna.2022.07.008_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neures.2010.12.007","article-title":"Regulation and function of immediate-early genes in the brain: beyond neuronal activity markers","volume":"69","author":"Okuno","year":"2011","journal-title":"Neurosci Res"},{"issue":"20","key":"10.1016\/j.mcna.2022.07.008_bib15","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1073\/pnas.191352698","article-title":"DeltaFosB: a sustained molecular switch for addiction","volume":"98","author":"Nestler","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.mcna.2022.07.008_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/cne.20417","article-title":"Laterodorsal tegmental projections to identified cell populations in the rat ventral tegmental area","volume":"483","author":"Omelchenko","year":"2005","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.mcna.2022.07.008_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-neuro-061010-113734","article-title":"Reward, addiction, withdrawal to nicotine","volume":"34","author":"De Biasi","year":"2011","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"10.1016\/j.mcna.2022.07.008_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/her\/cyh054","article-title":"Ambivalence and uncertainty: experiences of and attitudes towards addiction and smoking cessation in the mid-to-late teens","volume":"21","author":"Amos","year":"2006","journal-title":"Health Educ Res"},{"key":"10.1016\/j.mcna.2022.07.008_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12913-015-0854-8","article-title":"Effectiveness of chronic care models: opportunities for improving healthcare practice and health outcomes: a systematic review","volume":"15","author":"Davy","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.mcna.2022.07.008_bib20","unstructured":"Fiore M, United States. Tobacco Use and Dependence Guideline Panel. Treating tobacco use and dependence: 2008 update. 2008 update ed. Rockville, Md.: U.S. Dept. of Health and Human Services, Public Health Service; 2008."},{"issue":"2","key":"10.1016\/j.mcna.2022.07.008_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1513\/AnnalsATS.202008-971CME","article-title":"Summary for Clinicians: An ATS Clinical Practice Guideline for Initiating Pharmacologic Treatment in Tobacco-Dependent Adults","volume":"18","author":"Galiatsatos","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.mcna.2022.07.008_bib22","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1164\/rccm.202005-1982ST","article-title":"Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline","volume":"202","author":"Leone","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"25","key":"10.1016\/j.mcna.2022.07.008_bib23","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents","volume":"72","author":"Barua","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2022.07.008_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/7854_2009_29","article-title":"Novel pharmacological approaches to drug abuse treatment","volume":"3","author":"Edens","year":"2010","journal-title":"Curr Top Behav Neurosci"},{"issue":"2","key":"10.1016\/j.mcna.2022.07.008_bib25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bcp.12116","article-title":"Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice","volume":"77","author":"Aubin","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"9\u201310","key":"10.1016\/j.mcna.2022.07.008_bib26","first-page":"885","article-title":"Misperceptions of nicotine replacement therapy within racially and ethnically diverse smokers","volume":"103","author":"Carpenter","year":"2011","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/14622200310001656894","article-title":"Misuse of and dependence on over-the-counter nicotine gum in a volunteer sample","volume":"6","author":"Hughes","year":"2004","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"10.1016\/j.mcna.2022.07.008_bib28","first-page":"425","article-title":"Nicotine Replacement Therapy: An Overview","volume":"10","author":"Wadgave","year":"2016","journal-title":"Int J Health Sci (Qassim)"},{"key":"10.1016\/j.mcna.2022.07.008_bib29","first-page":"CD000146","article-title":"Nicotine replacement therapy versus control for smoking cessation","volume":"5","author":"Hartmann-Boyce","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.mcna.2022.07.008_bib30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/14622200412331324938","article-title":"The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations","volume":"6","author":"Colrain","year":"2004","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.mcna.2022.07.008_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1617-9625-8-8","article-title":"Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals","volume":"8","author":"Mills","year":"2010","journal-title":"Tob Induc Dis"},{"issue":"3","key":"10.1016\/j.mcna.2022.07.008_bib32","first-page":"106","article-title":"15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL","volume":"7","author":"Fava","year":"2005","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1385\/COMP:32:1:26","article-title":"Bupropion for smoking cessation: a review","volume":"32","author":"Tong","year":"2006","journal-title":"Compr Ther"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/COPD.S1121","article-title":"The use of bupropion SR in cigarette smoking cessation","volume":"3","author":"Wilkes","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.mcna.2022.07.008_bib35","article-title":"Antidepressants for smoking cessation","volume":"4","author":"Howes","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.mcna.2022.07.008_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A\u00a0controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.mcna.2022.07.008_bib37","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1111\/add.12304","article-title":"Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice","volume":"108","author":"Stapleton","year":"2013","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.mcna.2022.07.008_bib38","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/oby.2002.142","article-title":"Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms","volume":"10","author":"Jain","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/j.mcna.2022.07.008_bib39","unstructured":"Overview of Alcohol Consumption, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Available from: https:\/\/www.niaaa.nih.gov\/alcohols-effects-health\/overview-alcohol-consumption."},{"issue":"2","key":"10.1016\/j.mcna.2022.07.008_bib40","first-page":"239","article-title":"Smoking cessation therapy with varenicline","volume":"3","author":"Mohanasundaram","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"10.1016\/j.mcna.2022.07.008_bib41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/03007995.2020.1729708","article-title":"Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations","volume":"36","author":"Tonstad","year":"2020","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0026-895X(25)09896-7","article-title":"Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit","volume":"45","author":"Papke","year":"1994","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2021.7621","article-title":"Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial","volume":"326","author":"Courtney","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mcna.2022.07.008_bib44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jnci\/djx240","volume":"110","author":"Leas","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.mcna.2022.07.008_bib45","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/jnci\/djz001","article-title":"Factors That Explain Differences in Abstinence Between Black and White Smokers: A Prospective Intervention Study","volume":"111","author":"Nollen","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.mcna.2022.07.008_bib46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/add.13592","article-title":"The Food and Drug Administration and varenicline: should risk communication be improved?","volume":"112","author":"Davies","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.mcna.2022.07.008_bib47","doi-asserted-by":"crossref","first-page":"102557","DOI":"10.1016\/j.jhealeco.2021.102557","article-title":"Information shocks and pharmaceutical firms' marketing efforts: Evidence from the Chantix black box warning removal","volume":"81","author":"Lawler","year":"2022","journal-title":"J\u00a0Health Econ"},{"issue":"10037","key":"10.1016\/j.mcna.2022.07.008_bib48","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mcna.2022.07.008_bib49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ntr\/ntn031","article-title":"Varenicline and bupropion sustained-release combination therapy for smoking cessation","volume":"11","author":"Ebbert","year":"2009","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.mcna.2022.07.008_bib50","unstructured":"United States. Public Health Service. Office of the Surgeon General. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease : a report of the Surgeon General. Washington, (DC): U.S. Dept. of Health and Human Services, Public Health Service."},{"issue":"305","key":"10.1016\/j.mcna.2022.07.008_bib51","first-page":"1","article-title":"Cigarette Smoking During Pregnancy: United States, 2016","author":"Drake","year":"2018","journal-title":"NCHS Data Brief"},{"issue":"5","key":"10.1016\/j.mcna.2022.07.008_bib52","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1097\/AOG.0000000000003822","article-title":"Tobacco and Nicotine Cessation During Pregnancy: ACOG Committee Opinion, Number 807","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.mcna.2022.07.008_bib53","first-page":"CD001055","article-title":"Psychosocial interventions for supporting women to stop smoking in pregnancy","volume":"2","author":"Chamberlain","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2022.07.008_bib54","first-page":"CD010078","article-title":"Pharmacological interventions for promoting smoking cessation during pregnancy","volume":"3","author":"Claire","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.mcna.2022.07.008_bib55","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/add.13029","article-title":"Changes in the rate of nicotine metabolism across pregnancy: a longitudinal study","volume":"110","author":"Bowker","year":"2015","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.mcna.2022.07.008_bib56","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/FTD.0000000000000885","article-title":"Pregnancy Has No Clinically Significant Effect on the Pharmacokinetics of Bupropion or Its Metabolites","volume":"43","author":"Fay","year":"2021","journal-title":"Ther Drug Monit"},{"issue":"4","key":"10.1016\/j.mcna.2022.07.008_bib57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ajog.2016.11.1036","article-title":"Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial","volume":"216","author":"Nanovskaya","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.mcna.2022.07.008_bib58","doi-asserted-by":"crossref","first-page":"100315","DOI":"10.1016\/j.ajogmf.2021.100315","article-title":"Placebo-controlled trial of bupropion for smoking cessation in pregnant women","volume":"3","author":"Kranzler","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"10","key":"10.1016\/j.mcna.2022.07.008_bib59","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/ntr\/ntab063","volume":"23","author":"Choi","year":"2021","journal-title":"Nicotine Tob Res"},{"issue":"8","key":"10.1016\/j.mcna.2022.07.008_bib60","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/ntr\/nty055","article-title":"Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy","volume":"21","author":"Turner","year":"2019","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12916-019-1472-9","article-title":"Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study","volume":"18","author":"Tran","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0749-3797(02)00574-3","article-title":"Trends in smoking before, during, and after pregnancy in ten states","volume":"24","author":"Colman","year":"2003","journal-title":"Am J Prev Med"},{"year":"2020","series-title":"2019 National Survey on Drug Use and health: Detailed Tables","key":"10.1016\/j.mcna.2022.07.008_bib63"},{"key":"10.1016\/j.mcna.2022.07.008_bib64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2017.12.012","article-title":"Complement system biomarkers in first episode psychosis","volume":"204","author":"Kopczynska","year":"2019","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib65","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/eip.12542","article-title":"Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients experiencing first episode psychosis: data from the national RAISE-ETP study","volume":"13","author":"Oluwoye","year":"2019","journal-title":"Early Interv Psychiatry"},{"year":"2007","series-title":"Physician behavior and practice patterns related to smoking cessation","key":"10.1016\/j.mcna.2022.07.008_bib66"},{"key":"10.1016\/j.mcna.2022.07.008_bib67","first-page":"CD013522","article-title":"Smoking cessation for improving mental health","volume":"3","author":"Taylor","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2022.07.008_bib68","doi-asserted-by":"crossref","first-page":"h4065","DOI":"10.1136\/bmj.h4065","article-title":"Smoking cessation and reduction in people with chronic mental illness","volume":"351","author":"Tidey","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.mcna.2022.07.008_bib69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.9740\/mhc.2018.03.078","article-title":"Review of pharmacotherapy for smoking cessation in patients with schizophrenia","volume":"8","author":"Shawen","year":"2018","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.mcna.2022.07.008_bib70","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fpsyt.2018.00428","article-title":"Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis","volume":"9","author":"Ahmed","year":"2018","journal-title":"Front Psychiatry"},{"issue":"10","key":"10.1016\/j.mcna.2022.07.008_bib71","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/17476348.2017.1361823","article-title":"Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders","volume":"11","author":"Das","year":"2017","journal-title":"Expert Rev Respir Med"},{"issue":"12","key":"10.1016\/j.mcna.2022.07.008_bib72","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamapsychiatry.2013.2182","article-title":"Partnership between tobacco control programs and offices of mental health needed to reduce smoking rates in the United States","volume":"70","author":"Williams","year":"2013","journal-title":"JAMA Psychiatry."},{"key":"10.1016\/j.mcna.2022.07.008_bib73","unstructured":"United States. Department of Health and Human Services, National Center for Chronic Disease Prevention and Health Promotion (U.S.). Office on Smoking and Health. Tobacco use among U.S. racial\/ethnic minority groups. Atlanta, Ga.: Dept. of Health and Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion For sale by the Supt. of Docs., U.S. G.P.O.; 1998."},{"issue":"8","key":"10.1016\/j.mcna.2022.07.008_bib74","doi-asserted-by":"crossref","first-page":"e0200827","DOI":"10.1371\/journal.pone.0200827","article-title":"Patterns in first and daily cigarette initiation among youth and young adults from 2002 to 2015","volume":"13","author":"Cantrell","year":"2018","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2022.07.008_bib75","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/ntr\/ntv250","article-title":"Understanding Tobacco Use Onset Among African Americans","volume":"18","author":"Roberts","year":"2016","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.mcna.2022.07.008_bib76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pmedr.2016.12.008","article-title":"Race\/ethnicity and intention to quit cigarette smoking","volume":"5","author":"Soulakova","year":"2017","journal-title":"Prev Med Rep"},{"issue":"52","key":"10.1016\/j.mcna.2022.07.008_bib77","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.15585\/mmwr.mm6552a1","article-title":"Quitting Smoking Among Adults - United States, 2000-2015","volume":"65","author":"Babb","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.mcna.2022.07.008_bib78","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2105\/AJPH.2010.191668","article-title":"A\u00a0nationwide analysis of US racial\/ethnic disparities in smoking behaviors, smoking cessation, and cessation-related factors","volume":"101","author":"Trinidad","year":"2011","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib79","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/tobaccocontrol-2013-051159","article-title":"Differential trends in cigarette smoking in the USA: is menthol slowing progress?","volume":"24","author":"Giovino","year":"2015","journal-title":"Tob Control"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib80","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1186\/s12889-017-4987-z","article-title":"Menthol cigarettes and the public health standard: a systematic review","volume":"17","author":"Villanti","year":"2017","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib81","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/00952990.2021.1977310","article-title":"Racial\/ethnic group comparisons of quit ratios and prevalences of cessation-related factors among adults who smoke with a quit attempt","volume":"48","author":"Carroll","year":"2022","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.mcna.2022.07.008_bib82","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.pec.2019.08.023","article-title":"Race moderates the effects of Motivational Interviewing on smoking cessation induction","volume":"103","author":"Grobe","year":"2020","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.mcna.2022.07.008_bib83","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/DDDT.S10033","article-title":"Targeting nicotine addiction: the possibility of a therapeutic vaccine","volume":"5","author":"Escobar-Chavez","year":"2011","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib84","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14329","article-title":"Current status of immunotherapies for addiction","volume":"1489","author":"Xu","year":"2021","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.mcna.2022.07.008_bib85","first-page":"CD007072","article-title":"Nicotine vaccines for smoking cessation","author":"Hartmann-Boyce","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.mcna.2022.07.008_bib86","doi-asserted-by":"crossref","first-page":"e2547","DOI":"10.1371\/journal.pone.0002547","article-title":"A\u00a0vaccine against nicotine for smoking cessation: a randomized controlled trial","volume":"3","author":"Cornuz","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mcna.2022.07.008_bib87","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.2010.317","article-title":"Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic","volume":"89","author":"Hatsukami","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.mcna.2022.07.008_bib88","doi-asserted-by":"crossref","first-page":"120098","DOI":"10.1016\/j.jns.2021.120098","article-title":"Current status of vaccines for substance use disorders: A brief review of human studies","volume":"434","author":"Truong","year":"2022","journal-title":"J\u00a0Neurol Sci"},{"issue":"3","key":"10.1016\/j.mcna.2022.07.008_bib89","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s13311-017-0542-y","article-title":"Potential Therapeutic Effects of Psilocybin","volume":"14","author":"Johnson","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.mcna.2022.07.008_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"7","key":"10.1016\/j.mcna.2022.07.008_bib91","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/0269881116684335","article-title":"An online survey of tobacco smoking cessation associated with naturalistic psychedelic use","volume":"31","author":"Johnson","year":"2017","journal-title":"J\u00a0Psychopharmacol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:46:19Z","timestamp":1758419179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712522000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0025712522000906"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2022.07.008","relation":{},"ISSN":["0025-7125"],"issn-type":[{"type":"print","value":"0025-7125"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initiating Pharmacologic Treatment in Tobacco-Dependent Adults","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2022.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}